Mirae Asset Global Investments Co. Ltd. purchased a new stake in Incannex Healthcare Inc. (NASDAQ:IXHL – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 81,747 shares of the company’s stock, valued at approximately $379,000. Mirae Asset Global Investments Co. Ltd. owned about 0.13% of Incannex Healthcare as of its most recent filing with the Securities & Exchange Commission.
Incannex Healthcare Trading Down 3.5 %
Incannex Healthcare stock opened at $2.22 on Friday. The stock has a 50-day moving average of $3.59 and a two-hundred day moving average of $3.22. Incannex Healthcare Inc. has a one year low of $0.80 and a one year high of $12.68.
Incannex Healthcare (NASDAQ:IXHL – Get Free Report) last announced its quarterly earnings data on Wednesday, February 14th. The company reported ($0.33) earnings per share for the quarter.
About Incannex Healthcare
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
See Also
- Five stocks we like better than Incannex Healthcare
- Trading Stocks: RSI and Why it’s Useful
- 3 Stocks Leading the U.S. Agriculture Comeback
- Quiet Period Expirations Explained
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What is the Dogs of the Dow Strategy? Overview and Examples
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.